Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

Completed · Phase 3

Conditions studied: Chronic Idiopathic Constipation

In brief

This is a multi-center, open-label, 52-week safety and tolerability study of plecanatide in patients with Chronic Idiopathic Constipation (CIC).

Key facts

Study ID
NCT01919697
Run by
Bausch Health Americas, Inc.
People needed
2370
Starts
2013-08-01
Expected to finish
2016-03-01
Last updated by the study team
2019-07-02

Who can join

Age: 18 and older, up to 81. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.